Lexicon Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (31)

Latest Posts

About This Stock More About This Stock
4 Drug/Biotech Stocks Set To Outpace Q4 Earnings Estimates
Article By: Zacks Investment Research
Saturday, February 20, 2021 9:00 AM EDT
While almost all big drugmakers have reported their results, several smaller drug and biotech companies are yet to report this earnings season.
In this article: LXRX, MRNA, ADMA, BNTX Also: AVIR
2 Promising Biotech Stocks For More Than A Beer But Less Than A Martini
Article By: Bret Jensen
Thursday, November 5, 2015 2:26 PM EDT
The sector had dipped a toe into “official” bear market territory back in late September.
In this article: LXRX, TRVN Also: AMGN, GILD
Buy These 2 Small Biotechs With Huge Upside
Article By: Bret Jensen
Sunday, September 13, 2015 1:54 PM EDT
It's important to have 50% to 75% of one’s biotech portfolio in the large cap growth stocks but it also pays to take small stakes in a myriad of speculative but promising small cap companies in this lucrative space.
In this article: LXRX, AMGN, CELG, GILD, REGN, TTPH
Lexicon Reports Positive Phase 3 Results In Patients With Carcinoid Syndrome
Article By: Terry Chrisomalis
Monday, August 3, 2015 10:16 PM EDT
Shares of Lexicon surged 61% today after reporting positive phase 3 results in patients with carcinoid syndrome
In this article: LXRX, IPSEY

Latest Tweets for $LXRX

No tweets yet!